GRANULES INDIA Financial Statement Analysis
|
||
|
The Revenues of GRANULES INDIA have decreased by -0.55% YoY .
The Earnings Per Share (EPS) of GRANULES INDIA has increased by 16.10 % YoY. |
||
GRANULES INDIA Last 5 Annual Financial Results
[BOM: 532482|NSE : GRANULES]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹4,482 Cr | ₹4,506 Cr | ₹4,512 Cr | ₹3,765 Cr | ₹32,375 Cr |
| Expenses | ₹3,536 Cr | ₹3,650 Cr | ₹3,599 Cr | ₹3,043 Cr | ₹23,823 Cr |
| Operating Profit (Excl OI) | ₹945 Cr | ₹856 Cr | ₹913 Cr | ₹722 Cr | ₹8,552 Cr |
| Other Income | ₹13 Cr | ₹4.40 Cr | ₹14 Cr | ₹18 Cr | ₹269 Cr |
| Interest | ₹103 Cr | ₹106 Cr | ₹56 Cr | ₹23 Cr | ₹263 Cr |
| Depreciation | ₹226 Cr | ₹207 Cr | ₹184 Cr | ₹159 Cr | ₹1,515 Cr |
| Profit Before Tax | ₹660 Cr | ₹547 Cr | ₹687 Cr | ₹558 Cr | ₹7,044 Cr |
| Profit After Tax | ₹502 Cr | ₹405 Cr | ₹517 Cr | ₹413 Cr | ₹5,495 Cr |
| Consolidated Net Profit | ₹502 Cr | ₹405 Cr | ₹517 Cr | ₹413 Cr | ₹5,495 Cr |
| Earnings Per Share (Rs) | ₹24.01 | ₹20.68 | ₹16.72 | ₹21.34 | ₹16.64 |
| PAT Margin (%) | 5.94 | 6.73 | 6.19 | 11.45 | 10.96 |
| ROE(%) | 14.13 | 14.52 | 13.46 | 19.18 | 17.49 |
| ROCE(%) | 15.74 | 16.16 | 15.66 | 19.63 | 17.37 |
| Total Debt/Equity(x) | 0.28 | 0.35 | 0.38 | 0.38 | 0.43 |
Key Financials |
||
| Market Cap | : | ₹ 20,519.1 Cr |
| Revenue (TTM) | : | ₹ 5,632.3 Cr |
| Net Profit(TTM) | : | ₹ 662.3 Cr |
| EPS (TTM) | : | ₹ 26.7 |
| P/E (TTM) | : | 31.0 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| GRANULES INDIA | -2.1% | 0.5% | 81.5% |
| SUN PHARMACEUTICAL INDUSTRIES | 2% | -1.7% | 15.9% |
| DIVIS LABORATORIES | 6.5% | 14.8% | 48.4% |
| TORRENT PHARMACEUTICALS | 1.2% | -2.5% | 37.2% |
| CIPLA | -0.3% | -3.9% | -11.4% |
| DR REDDYS LABORATORIES | -2.2% | 1.5% | -8.3% |
| MANKIND PHARMA | 1.4% | -2.9% | -6.7% |
| LUPIN | 0.1% | -9.8% | 10.7% |
| ZYDUS LIFESCIENCES | 2.8% | 3.2% | 16% |
GRANULES INDIA Revenues
[BOM: 532482|NSE : GRANULES]
| Y-o-Y | -0.55 % |
| 5 Yr CAGR | -39.00 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,482 Cr | -0.55 | |
| Mar2025 | ₹4,506 Cr | -0.12 | |
| Mar2024 | ₹4,512 Cr | 19.84 | |
| Mar2023 | ₹3,765 Cr | -88.37 | |
| Mar2022 | ₹32,375 Cr | - | |
GRANULES INDIA Operating Profit
[BOM: 532482|NSE : GRANULES]
| Y-o-Y | 10.43 % |
| 5 Yr CAGR | -42.34 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹945 Cr | 10.43 | |
| Mar2025 | ₹856 Cr | -6.28 | |
| Mar2024 | ₹913 Cr | 26.56 | |
| Mar2023 | ₹722 Cr | -91.56 | |
| Mar2022 | ₹8,552 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 11.06 % |
| 5 Yr CAGR | -5.48 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 21.09% | 11.06 | |
| Mar2025 | 18.99% | -6.18 | |
| Mar2024 | 20.24% | 5.58 | |
| Mar2023 | 19.17% | -27.44 | |
| Mar2022 | 26.42% | - | |
GRANULES INDIA Profit After Tax
[BOM: 532482|NSE : GRANULES]
| Y-o-Y | 23.74 % |
| 5 Yr CAGR | -45.03 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹502 Cr | 23.74 | |
| Mar2025 | ₹405 Cr | -21.54 | |
| Mar2024 | ₹517 Cr | 25.16 | |
| Mar2023 | ₹413 Cr | -92.49 | |
| Mar2022 | ₹5,495 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -11.74 % |
| 5 Yr CAGR | -14.20 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 5.94 % | -11.74 | |
| Mar2025 | 6.73 % | 8.72 | |
| Mar2024 | 6.19 % | -45.94 | |
| Mar2023 | 11.45 % | 4.47 | |
| Mar2022 | 10.96 % | - | |
GRANULES INDIA Earnings Per Share (EPS)
[BOM: 532482|NSE : GRANULES]
| Y-o-Y | 16.10 % |
| 5 Yr CAGR | 9.60 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹24 | 16.10 | |
| Mar2025 | ₹21 | 23.68 | |
| Mar2024 | ₹17 | -21.65 | |
| Mar2023 | ₹21 | 28.25 | |
| Mar2022 | ₹17 | - | |
GRANULES INDIA Return on Capital Employed (ROCE)
[BOM: 532482|NSE : GRANULES]
| Y-o-Y | -2.60 % |
| 5 Yr CAGR | -2.43 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 15.74% | -2.60 | |
| Mar2025 | 16.16% | 3.19 | |
| Mar2024 | 15.66% | -20.22 | |
| Mar2023 | 19.63% | 13.01 | |
| Mar2022 | 17.37% | - | |
GRANULES INDIA Share Price vs Sensex
| Current Share Price | : | ₹828.1 |
| Current MarketCap | : | ₹ 20,519.1 Cr |
| Updated EOD on | : | Aug 31,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GRANULES INDIA | -2.1% |
0.5% |
81.5% |
| SENSEX | -0.5% |
-1.3% |
-5.4% |
GRANULES INDIA related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | 2% | 1.7% | 15.1% |
| BSE 500 MOMENTUM 50 | 0.7% | 5.5% | 8.8% |
| BSE 400 MIDSMALLCAP INDEX | 0% | 2.3% | 7.6% |
| BSE 250 SMALLCAP INDEX | -0.1% | 2.8% | 6% |
| BSE 1000 | -0.4% | 0.6% | 2.2% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY500 HEALTHCARE INDEX | 2.5% | 1.7% | 14.2% |
| NIFTY MIDSMALL HEALTHCARE | 1.7% | 1.4% | 17.4% |
| NIFTY500 MOMENTUM 50 | 1.5% | 6.7% | 7.4% |
| NIFTY MIDSMALLCAP400 MOMENTUM QUALITY 100 INDEX | 1% | 3.9% | 8.7% |
| NIFTY500 SHARIAH | 0.5% | 0.7% | -0.2% |
You may also like the below Video Courses
FAQ about GRANULES INDIA Financials
How the annual revenues of GRANULES INDIA have changed ?
The Revenues of GRANULES INDIA have decreased by -0.55% YoY .
How the Earnings per Share (EPS) of GRANULES INDIA have changed?
The Earnings Per Share (EPS) of GRANULES INDIA has increased by 16.10 % YoY .
Check out Intrinsic Value of Peers of GRANULES INDIA
Compare Stock Analytics of Peers of GRANULES INDIA
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
